EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

A systematic review of early phase studies for children and young people with relapsed and refractory rhabdomyosarcoma: The REFoRMS‐SR project

Eine systematische Übersicht früher Phasenstudien bei Kindern und Jugendlichen mit rezidiviertem und refraktärem Rhabdomyosarkom: das REFoRMS-SR-Projekt

Connor Evans, Lucy Shepherd, Gemma Bryan, Helen Fulbright, Scott Crowther, Sara Wakeling, Andy Stewart, Claire Stewart, Julia Chisholm, Faith Gibson, Bob Phillips, Jessica E Morgan iD

International Journal of Cancer · 2024-04 · 154 (7) · 1235-1260

DOI: 10.1002/ijc.34808 ↗

Auf einen Blick

Die Übersicht zu frühen Studien bei Kindern und Jugendlichen mit rezidiviertem/refraktärem Rhabdomyosarkom fand insgesamt ungünstige Ergebnisse. Die objektive Ansprechrate betrug 21,6 %.

Fragestellung

Welche Ergebnisse zeigen frühe Studien zu Interventionen bei Patient:innen unter 18 Jahren mit rezidiviertem oder refraktärem Rhabdomyosarkom?

Methode

Systematische Übersicht früher Phasenstudien; Suche in 9 Datenbanken und 5 Studienregistern im Juni 2021; narrative Synthese wegen Heterogenität.

Ergebnisse

129 veröffentlichte Studien mit über 1100 Patient:innen waren einschlussfähig. 70 % der Studien mit Median des progressionsfreien Überlebens ≤6 Monate. Unerwünschte Ereignisse waren meist hämatologisch.

Einschränkungen

Studienqualität durch unvollständige und inkonsistente Berichterstattung begrenzt.

Schlussfolgerung der Autor:innen

Die Ergebnisse für Kinder mit rezidiviertem/refraktärem Rhabdomyosarkom in frühen Studien sind schlecht. Bessere und einheitlichere Berichterstattung würde die Synthese erleichtern.

Kernaussagen

  • Objektive Ansprechrate: 21,6 %
  • 70 % der Studien mit PFS-Median ≤6 Monate
  • Unerwünschte Ereignisse meist hämatologisch

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Cancer, online erschienen am 10.12.2023. Verfasst von Connor Evans und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Reviews and Dissemination, University of York, York, UK. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Great Ormond Street Hospital BRC, Children's Cancer and Leukaemia Group, Giant Pledge through the Royal Marsden Cancer Charity.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhabdomyosarcoma is the commonest soft tissue sarcoma in children. Around one‐third of children with rhabdomyosarcoma experience relapse or have refractory disease, which is associated with a poor prognosis. This systematic review of early phase studies in pediatric relapsed/refractory rhabdomyosarcoma was conducted to inform future research and provide accurate information to families and clinicians making difficult treatment choices. Nine databases and five trial registries were searched in June 2021. Early phase studies of interventions for disease control in patients under 18 years old with relapsed/refractory rhabdomyosarcoma were eligible. No language/geographic restrictions were applied. Studies conducted after 2000 were included. Survival outcomes, response rates, quality of life and adverse event data were extracted. Screening, data extraction and quality assessment (Downs and Black Checklist) were conducted by two researchers. Owing to heterogeneity in the included studies, narrative synthesis was conducted. Of 16,965 records screened, 129 published studies including over 1100 relapsed/refractory rhabdomyosarcoma patients were eligible. Most studies evaluated systemic therapies. Where reported, 70% of studies reported a median progression‐free survival ≤6 months. Objective response rate was 21.6%. Adverse events were mostly hematological. One‐hundred and seven trial registry records of 99 studies were also eligible, 63 of which report they are currently recruiting. Study quality was limited by poor and inconsistent reporting. Outcomes for children with relapsed/refractory rhabdomyosarcoma who enroll on early phase studies are poor. Improving reporting quality and consistency would facilitate the synthesis of early phase studies in relapsed/refractory rhabdomyosarcoma (PROSPERO registration: CRD42021266254).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyosarcomaNeoplasm Recurrence, LocalHumansChildAdolescentChild, PreschoolQuality of LifeProgression-Free Survival

Stichwörter der Autor:innen

childhood cancerrefractoryrelapserhabdomyosarcomasystematic review

Autor:innen und Institutionen

  • Centre for Reviews and Dissemination, University of York, York, UK.
  • School of Health Sciences, University of Surrey, Guildford, UK.
  • Pass the Smile for Ben, Coventry, UK.
  • Alice's Arc, London, England, UK.
  • Be More Ruby, Perth, Scotland, UK.
  • Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK.

ORCID-Profile: Jessica E Morgan

Förderung

  • NIHR Great Ormond Street Hospital BRC
  • Children's Cancer and Leukaemia Group
  • Giant Pledge through the Royal Marsden Cancer Charity
  • Medical Research Council
  • Institute of Cancer Research, London
  • National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust
  • CCLG
  • NIHR Great Ormond Street Hospital Biomedical Research Centre

Zitieren

APA

Evans, C., Shepherd, L., Bryan, G., Fulbright, H., Crowther, S., Wakeling, S., Stewart, A., Stewart, C., Chisholm, J., Gibson, F., Phillips, B., & Morgan, J. E. (2024). A systematic review of early phase studies for children and young people with relapsed and refractory rhabdomyosarcoma: The REFoRMS‐SR project. International Journal of Cancer, 154(7), 1235-1260. https://doi.org/10.1002/ijc.34808

Vancouver

Evans C, Shepherd L, Bryan G, Fulbright H, Crowther S, Wakeling S, et al. A systematic review of early phase studies for children and young people with relapsed and refractory rhabdomyosarcoma: The REFoRMS‐SR project. International Journal of Cancer. 2024;154(7):1235-1260. doi:10.1002/ijc.34808

BibTeX
@article{Evans2024,
  author = {Evans, Connor and Shepherd, Lucy and Bryan, Gemma and Fulbright, Helen and Crowther, Scott and Wakeling, Sara and Stewart, Andy and Stewart, Claire and Chisholm, Julia and Gibson, Faith and Phillips, Bob and Morgan, Jessica E},
  title = {A systematic review of early phase studies for children and young people with relapsed and refractory rhabdomyosarcoma: The REFoRMS‐SR project},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {154},
  number = {7},
  pages = {1235--1260},
  doi = {10.1002/ijc.34808}
}
Kostenlos starten →